Platelet-rich plasma versus carboxytherapy in the treatment of periorbital dark circles: A split-face study

J Cosmet Dermatol. 2022 Oct;21(10):4332-4338. doi: 10.1111/jocd.15051. Epub 2022 Aug 1.

Abstract

Background: Periorbital hyperpigmentation is a recurrent problem in dermatologic clinics that affect the patients' quality of life and their psychological status. Platelet-rich plasma (PRP) may serve as a source of different growth factors which may reduce the pigmentation in this problem. Carboxytherapy is carbon dioxide infusion into human tissue for therapeutic purposes.

Objective: To evaluate and compare the clinical efficacy of PRP and carboxytherapy in the treatment of periorbital dark circles (PODC). Histopathological evaluation was also done.

Patients and methods: Split-face study of 23 patients with PODC treated with PRP at the right side and carboxytherapy at the left side. Patients received four sessions; one session/week. Final follow-up evaluation was done 3 months after the last session by clinical and histopathological assessment.

Results: PRP showed significant better response (p = 0.002), shorter downtime, and tolerable side effects than caboxytherapy. Reduction in area percent of melanin after PRP injections showed 46.6% improvement, while after carboxytherapy, it showed only 14.3% improvement.

Conclusion: The present study showed that PRP is more effective and tolerable than caboxytherapy in the treatment of PODC.

Keywords: caboxytherapy; periorbital dark circles (PODC); platelet-rich plasma (PRP).

MeSH terms

  • Humans
  • Hyperpigmentation* / etiology
  • Hyperpigmentation* / radiotherapy
  • Injections, Intradermal / adverse effects
  • Patient Satisfaction
  • Platelet-Rich Plasma*
  • Quality of Life
  • Treatment Outcome